Peng Zhao

Prof. Peng Zhao

the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2020 in IEEE Transactions on Industrial Informatics
Verified
Journal Article
Closed access
Shuguang DengShuguang Deng
Shuguang Deng
ZXZhengzhe Xiang
Zhengzhe Xiang
PZPeng Zhao
Peng Zhao
Javid TaheriJavid Taheri
Javid Taheri
Honghao GaoHonghao Gao
Honghao Gao
Albert ZomayaAlbert Zomaya
Albert Zomaya
Edge computing (EC) is now emerging as a key paradigm to handle the increasing Internet-of-Things (IoT) devices connected to the edge of the network. These IoT devices are enabled to fulfill complex tasks effectively. Nevertheless, it also brings challenges in trustworthiness management. The volatile environment will make it difficult to comply with the service-level agreement (SLA), which is an important index of trustworthiness declared by these IoT services. In this paper, we first encode the state of the service provisioning system and the resource allocation scheme and model the adjustment of allocated resources for services as MDP. Based on these, we get a trained resource allocating policy. The trained policy can always maximize the services' trustworthiness gain by generating appropriate resource allocation schemes dynamically according to the system states. A series of experiments show that the system using our approach has 21.72% better performance at least compared to baselines.

3 April 2024 in Advanced Science
Verified
Journal Article
Open access
PDF file
CLChuan Liu
Chuan Liu
JXJindong Xie
Jindong Xie
BLBo Lin
Bo Lin
WTWeihong Tian
Weihong Tian
YWYifan Wu
Yifan Wu
PZPeng Zhao
Peng Zhao
The heterogeneity of macrophages influences the response to immune checkpoint inhibitor (ICI) therapy. However, few studies explore the impact of APOE + macrophages on ICI therapy using single‐cell RNA sequencing (scRNA‐seq) and machine learning methods. The scRNA‐seq and bulk RNA‐seq data are Integrated to construct an M.Sig model for predicting ICI response based on the distinct molecular signatures of macrophage and machine learning algorithms. Comprehensive single‐cell analysis as well as in vivo and in vitro experiments are applied to explore the potential mechanisms of the APOE + macrophage in affecting ICI response. The M.Sig model shows clear advantages in predicting the efficacy and prognosis of ICI therapy in pan‐cancer patients. The proportion of APOE + macrophages is higher in ICI non‐responders of triple‐negative breast cancer compared with responders, and the interaction and longer distance between APOE + macrophages and CD8 + exhausted T (Tex) cells affecting ICI response is confirmed by multiplex immunohistochemistry. In a 4T1 tumor‐bearing mice model, the APOE inhibitor combined with ICI treatment shows the best efficacy. The M.Sig model using real‐world immunotherapy data accurately predicts the ICI response of pan‐cancer, which may be associated with the interaction between APOE + macrophages and CD8 + Tex cells.

6 January 2024 in Biomaterials
Verified
Journal Article
Closed access
YJYuzhi Jin
Yuzhi Jin
YHYangyue Huang
Yangyue Huang
HRHui Ren
Hui Ren
HHHuanhuan Huang
Huanhuan Huang
CLChunyu Lai
Chunyu Lai
XDXiaomeng Dai
Xiaomeng Dai

1 September 2021 in Biomaterials
Verified
Journal Article
Closed access
YGYixuan Guo
Yixuan Guo
YLYu Liu
Yu Liu
WWWei Wu
Wei Wu
Daishun LingDaishun Ling
Daishun Ling
QZQiao Zhang
Qiao Zhang
XHXi Hu
Xi Hu

7 October 2020 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
XBXuanwen Bao
Xuanwen Bao
HZHangyu Zhang
Hangyu Zhang
WWWei Wu
Wei Wu
SCShaobing Cheng
Shaobing Cheng
XDXiaomeng Dai
Xiaomeng Dai
FLFanglong Liu
Fanglong Liu
Background: Microsatellite instability in colon cancer implies favorable therapeutic outcomes after checkpoint blockade immunotherapy. However, the molecular nature of microsatellite instability is not well elucidated. Methods: We examined the immune microenvironment of colon cancer using assessments of the bulk transcriptome and the single-cell transcriptome focusing on molecular nature of microsatellite stability (MSS) and microsatellite instability (MSI) in colorectal cancer from a public database. The association of the mutation pattern and microsatellite status was analyzed by a random forest algorithm in The Cancer Genome Atlas (TCGA) and validated by our in-house dataset (39 tumor mutational burden (TMB)-low MSS colon cancer, 10 TMB-high MSS colon cancer, 15 MSI colon cancer). A prognostic model was constructed to predict the survival potential and stratify microsatellite status by a neural network. Results: Despite the hostile CD8+ cytotoxic T lymphocyte (CTL)/Th1 microenvironment in MSI colon cancer, a high percentage of exhausted CD8+ T cells and upregulated expression of immune checkpoints were identified in MSI colon cancer at the single-cell level, indicating the potential neutralizing effect of cytotoxic T-cell activity by exhausted T-cell status. A more homogeneous highly expressed pattern of PD1 was observed in CD8+ T cells from MSI colon cancer; however, a small subgroup of CD8+ T cells with high expression of checkpoint molecules was identified in MSS patients. A random forest algorithm predicted important mutations that were associated with MSI status in the TCGA colon cancer cohort, and our in-house cohort validated higher frequencies of BRAF, ARID1A, RNF43, and KM2B mutations in MSI colon cancer. A robust microsatellite status–related gene signature was built to predict the prognosis and differentiate between MSI and MSS tumors. A neural network using the expression profile of the microsatellite status–related gene signature was constructed. A receiver operating characteristic curve was used to evaluate the accuracy rate of neural network, reaching 100%. Conclusion: Our analysis unraveled the difference in the molecular nature and genomic variance in MSI and MSS colon cancer. The microsatellite status–related gene signature is better at predicting the prognosis of patients with colon cancer and response to the combination of immune checkpoint inhibitor–based immunotherapy and anti-VEGF therapy.

20 May 2022 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
XBXuanwen Bao
Xuanwen Bao
QLQiong Li
Qiong Li
JCJinzhang Chen
Jinzhang Chen
DCDiyu Chen
Diyu Chen
CYChanqi Ye
Chanqi Ye
Jian RuanJian Ruan
Jian Ruan
Intrahepatic cholangiocarcinoma (ICC) is a relatively rare but highly aggressive tumor type that responds poorly to chemotherapy and immunotherapy. Comprehensive molecular characterization of ICC is essential for the development of novel therapeutics. Here, we constructed two independent cohorts from two clinic centers. A comprehensive multiomics analysis of ICC via proteomic, whole-exome sequencing (WES), and single-cell RNA sequencing (scRNA-seq) was performed. Novel ICC tumor subtypes were derived in the training cohort (n = 110) using proteomic signatures and their associated activated pathways, which were further validated in a validation cohort (n = 41). Three molecular subtypes, chromatin remodeling, metabolism, and chronic inflammation, with distinct prognoses in ICC were identified. The chronic inflammation subtype was associated with a poor prognosis. Our random forest algorithm revealed that mutation of lysine methyltransferase 2D (KMT2D) frequently occurred in the metabolism subtype and was associated with lower inflammatory activity. scRNA-seq further identified an APOE+C1QB+ macrophage subtype, which showed the capacity to reshape the chronic inflammation subtype and contribute to a poor prognosis in ICC. Altogether, with single-cell transcriptome-assisted multiomics analysis, we identified novel molecular subtypes of ICC and validated APOE+C1QB+ tumor-associated macrophages as potential immunotherapy targets against ICC.